Rodman & Renshaw Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Rodman & Renshaw
Rating: 2.8
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Rodman & Renshaw. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Rodman & Renshaw.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
BHC Bausch Health Companies	8/10/2017	Reiterated by	Rodman & Renshaw		Neutral	$17.00	High
CRMD CorMedix	8/10/2017	Target Lowered by	Rodman & Renshaw		Buy -> Buy	$25.00 -> $15.00	N/A
GEVO Gevo	8/9/2017	Reiterated by	Rodman & Renshaw		Buy	$240.00	Medium
POETF POET Technologies	8/7/2017	Initiated by	Rodman & Renshaw		Buy		High
VERU Veru	7/26/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$5.00	High
PLUG Plug Power	7/24/2017	Reiterated by	Rodman & Renshaw		Buy	$4.00	Low

CAPR Capricor Therapeutics	7/22/2017	Reiterated by	Rodman & Renshaw		Buy	$2.15	N/A
BYSI BeyondSpring	7/14/2017	Target Raised by	Rodman & Renshaw		Buy -> Buy	$43.00 -> $50.00	Medium
FBIO Fortress Biotech	7/11/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$11.00	Low
AQMS Aqua Metals	7/2/2017	Initiated by	Rodman & Renshaw		Buy	$25.00 -> $25.00	Low
EMAN eMagin	6/23/2017	Reiterated by	Rodman & Renshaw		Buy	$4.00	N/A
AQMS Aqua Metals	6/22/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$25.00	Low
USA Americas Silver	6/15/2017	Initiated by	Rodman & Renshaw		Buy	C$4.00	N/A
USAS Americas Silver	6/15/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$4.00 -> $4.00	Medium
APTO Aptose Biosciences	6/8/2017	Initiated by	Rodman & Renshaw		Neutral -> Neutral		High
EYPT EyePoint Pharmaceuticals	5/30/2017	Initiated by	Rodman & Renshaw		Buy	$800.00	High
PIRS Pieris Pharmaceuticals	5/30/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$9.00	High
PLX Protalix BioTherapeutics	5/23/2017	Reiterated by	Rodman & Renshaw		Buy	$50.00	N/A
ACAD ACADIA Pharmaceuticals	5/22/2017	Reiterated by	Rodman & Renshaw		Buy	$60.00	Low
SRNE Sorrento Therapeutics	5/22/2017	Target Lowered by	Rodman & Renshaw		Buy -> Buy	$30.00 -> $20.00	High
BHC Bausch Health Companies	5/19/2017	Reiterated by	Rodman & Renshaw		Neutral	$17.00	Medium
MGIC Magic Software Enterprises	5/17/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$9.00 -> $10.00	Medium
SSKN STRATA Skin Sciences	5/16/2017	Target Raised by	Rodman & Renshaw		Buy -> Buy	$1.50 -> $12.00	High
IOVA Iovance Biotherapeutics	5/10/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$13.00	Low
CRMD CorMedix	5/5/2017	Target Lowered by	Rodman & Renshaw		Buy	$30.00 -> $25.00	N/A
AMSC American Superconductor	4/28/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$10.00 -> $7.50	High
ALIM Alimera Sciences	4/27/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$60.00	High
GOLD Barrick Gold	4/24/2017	Target Raised by	Rodman & Renshaw		Buy	C$4.25 -> C$4.50	N/A
PLX Protalix BioTherapeutics	4/17/2017	Target Raised by	Rodman & Renshaw		Buy	$40.00 -> $50.00	N/A
PLX Protalix BioTherapeutics	4/17/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$40.00 -> $50.00	N/A
WRN Western Copper and Gold	4/10/2017	Reiterated by	Rodman & Renshaw		Buy	C$2.00	N/A
WRN Western Copper and Gold	4/7/2017	Reiterated by	Rodman & Renshaw		Buy	$2.00	Medium
PLUG Plug Power	4/6/2017	Target Raised by	Rodman & Renshaw		Buy -> Buy	$3.00 -> $4.00	High
BYSI BeyondSpring	4/4/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$43.00	Low
CYTK Cytokinetics	3/23/2017	Reiterated by	Rodman & Renshaw		Buy	$25.00	Medium
HROW Harrow Health	3/22/2017	Reiterated by	Rodman & Renshaw		Buy	$5.00	High
EVOK Evoke Pharma	3/16/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$72.00 -> $108.00	High
MAG MAG Silver	3/9/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$20.00 -> $20.50	Low
CYTK Cytokinetics	3/8/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$25.00	High
BHC Bausch Health Companies	3/6/2017	Target Lowered by	Rodman & Renshaw		Neutral	$23.00 -> $17.00	N/A

MGIC Magic Software Enterprises	3/6/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$8.00 -> $9.00	N/A
QRHC Quest Resource	3/6/2017	Initiated by	Rodman & Renshaw		Buy -> Buy	$5.00	N/A
BHC Bausch Health Companies	2/27/2017	Reiterated by	Rodman & Renshaw		Neutral	$23.00 -> $17.00	N/A
SSKN STRATA Skin Sciences	2/21/2017	Reiterated by	Rodman & Renshaw		Buy -> Buy	$1.50	N/A
CAPR Capricor Therapeutics	2/13/2017	Initiated by	Rodman & Renshaw		Buy	$14.00	N/A
BLRX BioLineRx	2/13/2017	Initiated by	Rodman & Renshaw		Buy	$3.00	N/A
ARTH Arch Therapeutics	2/13/2017	Initiated by	Rodman & Renshaw		Buy	$2.50	N/A
ABEO Abeona Therapeutics	2/7/2017	Reiterated by	Rodman & Renshaw	Analyst ram selvaraju	Buy	$425.00 -> $500.00	N/A
ADES Advanced Emissions Solutions	2/6/2017	Initiated by	Rodman & Renshaw		Buy	$18.00	N/A
BHC Bausch Health Companies	1/31/2017	Downgraded by	Rodman & Renshaw		Buy -> Neutral		N/A
ASM Avino Silver & Gold Mines	1/24/2017	Target Raised by	Rodman & Renshaw		Buy	C$3.50 -> C$4.00	N/A
AMRS Amyris	1/11/2017	Reiterated by	Rodman & Renshaw		Buy	$60.00	N/A
EVOK Evoke Pharma	1/5/2017	Upgraded by	Rodman & Renshaw	Analyst Ram Selvaraju	Neutral -> Buy	$30.00 -> $72.00	N/A
CDXC ChromaDex	1/3/2017	Initiated by	Rodman & Renshaw		Buy	$6.00	N/A
EVOK Evoke Pharma	12/31/2016	Target Raised by	Rodman & Renshaw	Analyst Ram Selvaraju	Neutral	$24.00 -> $30.00	N/A
EVOK Evoke Pharma	12/23/2016	Target Raised by	Rodman & Renshaw	Analyst Ram Selvaraju	Neutral	$24.00 -> $30.00	N/A
PLUG Plug Power	12/6/2016	Initiated by	Rodman & Renshaw		Buy	$3.00	N/A
GOLD GoldMining	11/28/2016	Target Raised by	Rodman & Renshaw		Buy	C$4.00 -> C$4.25	N/A
HROW Harrow Health	11/28/2016	Initiated by	Rodman & Renshaw		Buy	$5.00	N/A
BHC Bausch Health Companies	11/10/2016	Downgraded by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy -> Neutral	$81.00 -> $23.00	N/A
NURO NeuroMetrix	10/21/2016	Reiterated by	Rodman & Renshaw	Analyst ram selvaraju	Buy	$36.00	N/A
GGD GoGold Resources	10/7/2016	Target Lowered by	Rodman & Renshaw		Buy	C$3.50 -> C$3.00	N/A
CYDY CytoDyn	10/6/2016	Initiated by	Rodman & Renshaw		Buy	$1.60	N/A
DRRX DURECT	9/27/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00 -> $35.00	N/A
AYTU Aytu BioPharma	9/26/2016	Initiated by	Rodman & Renshaw		Buy	$9.00	N/A
CLNE Clean Energy Fuels	9/23/2016	Reiterated by	Rodman & Renshaw		Buy	$5.00 -> $6.30	N/A
UUUU Energy Fuels	9/22/2016	Target Raised by	Rodman & Renshaw		Buy	$5.00 -> $6.30	N/A
UUUU Energy Fuels	9/22/2016	Target Lowered by	Rodman & Renshaw		Buy	$6.30 -> $5.00	N/A
VNRX VolitionRx	9/7/2016	Target Lowered by	Rodman & Renshaw		Buy	$12.00 -> $10.00	N/A
VNRX VolitionRx	9/7/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00 -> $10.00	N/A
MEEC Midwest Energy Emissions	9/7/2016	Initiated by	Rodman & Renshaw		Buy	$2.50	N/A
HL Hecla Mining	9/6/2016	Initiated by	Rodman & Renshaw		Buy	$9.00	N/A
NURO NeuroMetrix	9/4/2016	Target Set by	Rodman & Renshaw	Analyst ram selvaraju	Buy	$36.00	N/A
CANF Can-Fite BioPharma	8/29/2016	Initiated by	Rodman & Renshaw		Buy	$60.00	N/A
REI Ring Energy	8/29/2016	Initiated by	Rodman & Renshaw		Buy	$15.00	N/A
DRIO DarioHealth	8/22/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00	N/A
ORMP Oramed Pharmaceuticals	8/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$25.00	N/A
ABEO Abeona Therapeutics	8/21/2016	Reiterated by	Rodman & Renshaw		Buy	$425.00	N/A
SMT Sierra Metals	8/18/2016	Reiterated by	Rodman & Renshaw		Buy	C$3.00	N/A
BPTH Bio-Path	8/11/2016	Target Set by	Rodman & Renshaw	Analyst yi chen	Buy	$1,000.00	N/A
BHC Bausch Health Companies	8/9/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00 -> $81.00	N/A
ABEO Abeona Therapeutics	8/5/2016	Reiterated by	Rodman & Renshaw		Buy	$425.00	N/A
DRRX DURECT	8/3/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A
EKSO Ekso Bionics	7/31/2016	Reiterated by	Rodman & Renshaw		Buy		N/A
BHC Bausch Health Companies	7/28/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A
NURO NeuroMetrix	7/22/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
F Ford Motor	7/18/2016	Initiated by	Rodman & Renshaw		Buy		N/A
EVOK Evoke Pharma	7/18/2016	Downgraded by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy -> Neutral	$24.00	N/A
OESX Orion Energy Systems	7/18/2016	Initiated by	Rodman & Renshaw		Buy	$2.50	N/A
SRNE Sorrento Therapeutics	7/17/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A

BHC Bausch Health Companies	7/17/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A
BPTH Bio-Path	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
SRNE Sorrento Therapeutics	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
PLX Protalix BioTherapeutics	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
EVOK Evoke Pharma	7/11/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$324.00	N/A
BHC Bausch Health Companies	7/6/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$90.00	N/A
DRRX DURECT	7/6/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A
NURO NeuroMetrix	6/28/2016	Initiated by	Rodman & Renshaw		Buy	$36.00	N/A
INO Inovio Pharmaceuticals	6/21/2016	Reiterated by	Rodman & Renshaw		Buy	$17.00	N/A
WPRT Westport Fuel Systems	6/20/2016	Initiated by	Rodman & Renshaw		Buy	$5.00	N/A
VNRX VolitionRx	6/16/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
SRNE Sorrento Therapeutics	6/8/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
DRIO DarioHealth	5/24/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$12.00	N/A
ABEO Abeona Therapeutics	5/18/2016	Reiterated by	Rodman & Renshaw		Buy	$425.00	N/A
VNRX VolitionRx	5/16/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
DRRX DURECT	5/13/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A
ORMP Oramed Pharmaceuticals	5/13/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$25.00	N/A
EVOK Evoke Pharma	5/12/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
RGRX RegeneRx Biopharmaceuticals	5/10/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
DRIO DarioHealth	5/9/2016	Initiated by	Rodman & Renshaw		Buy	$12.00	N/A
BHC Bausch Health Companies	5/3/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$105.00 -> $102.00	N/A
RGRX RegeneRx Biopharmaceuticals	4/29/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$2.00	N/A
BHC Bausch Health Companies	4/26/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$105.00	N/A
DRRX DURECT	4/25/2016	Initiated by	Rodman & Renshaw		Buy	$40.00	N/A
VNRX VolitionRx	4/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
ABEO Abeona Therapeutics	4/20/2016	Reiterated by	Rodman & Renshaw		Buy	$425.00	N/A
BPTH Bio-Path	4/18/2016	Initiated by	Rodman & Renshaw		Buy	$1,000.00	N/A
AG First Majestic Silver	4/15/2016	Target Raised by	Rodman & Renshaw		Buy	$6.00 -> $8.75	N/A
SMLR Semler Scientific	4/15/2016	Initiated by	Rodman & Renshaw		Buy	$8.00	N/A
EXK Endeavour Silver	4/12/2016	Target Raised by	Rodman & Renshaw		Buy	$2.50 -> $3.40	N/A
BHC Bausch Health Companies	4/11/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$118.00 -> $105.00	N/A
INO Inovio Pharmaceuticals	4/9/2016	Reiterated by	Rodman & Renshaw		Buy		N/A
VNRX VolitionRx	4/9/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
SRNE Sorrento Therapeutics	4/5/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00 -> $30.00	N/A
EKSO Ekso Bionics	4/5/2016	Reiterated by	Rodman & Renshaw		Buy	$21.00	N/A
PLX Protalix BioTherapeutics	4/4/2016	Initiated by	Rodman & Renshaw		Buy	$35.00	N/A
BHC Bausch Health Companies	4/3/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
AMSC American Superconductor	4/1/2016	Reiterated by	Rodman & Renshaw	Analyst Amit Dayal	Neutral		N/A
BHC Bausch Health Companies	3/28/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$118.00	N/A
BHC Bausch Health Companies	3/22/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
SRNE Sorrento Therapeutics	3/21/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A
NNDM Nano Dimension	3/21/2016	Initiated by	Rodman & Renshaw		Buy	$700.00	N/A
INO Inovio Pharmaceuticals	3/20/2016	Reiterated by	Rodman & Renshaw		Buy		N/A
UUUU Energy Fuels	3/17/2016	Target Lowered by	Rodman & Renshaw		Buy	$6.90 -> $6.30	N/A
CRMD CorMedix	3/17/2016	Target Raised by	Rodman & Renshaw		Buy	$32.50 -> $37.50	N/A
BHC Bausch Health Companies	3/16/2016	Target Lowered by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$150.00 -> $118.00	N/A
MUX McEwen Mining	3/14/2016	Target Raised by	Rodman & Renshaw			$13.00 -> $24.00	N/A
EVOK Evoke Pharma	3/14/2016	Reiterated by	Rodman & Renshaw		Buy	$324.00	N/A
VNRX VolitionRx	3/14/2016	Reiterated by	Rodman & Renshaw		Buy	$12.00	N/A
RGRX RegeneRx Biopharmaceuticals	3/14/2016	Initiated by	Rodman & Renshaw		Buy	$2.00	N/A

INSG Inseego	3/7/2016	Target Lowered by	Rodman & Renshaw		Buy	$6.00 -> $3.00	N/A
EVOK Evoke Pharma	3/7/2016	Reiterated by	Rodman & Renshaw		Buy	$324.00	N/A
SRNE Sorrento Therapeutics	3/7/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$40.00	N/A
PLM PolyMet Mining	3/4/2016	Target Raised by	Rodman & Renshaw		Buy	$2.00 -> $2.40	N/A
BHC Bausch Health Companies	3/2/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy		N/A
AUMN Golden Minerals	2/29/2016	Reiterated by	Rodman & Renshaw		Buy	$0.60	N/A
AUMN Golden Minerals	2/29/2016	Target Raised by	Rodman & Renshaw		Buy	$0.60	N/A
SRNE Sorrento Therapeutics	2/29/2016	Target Lowered by	Rodman & Renshaw		Buy	$45.00 -> $40.00	N/A
AG First Majestic Silver	2/29/2016	Initiated by	Rodman & Renshaw		Buy	$6.00	N/A
EXK Endeavour Silver	2/29/2016	Initiated by	Rodman & Renshaw		Buy	$2.50	N/A
BHC Bausch Health Companies	2/23/2016	Reiterated by	Rodman & Renshaw	Analyst Ram Selvaraju	Buy	$150.00	N/A
PVG Pretium Resources	2/20/2016	Reiterated by	Rodman & Renshaw		Buy	$13.20 -> $14.50	N/A
RDCM RADCOM	2/18/2016	Target Raised by	Rodman & Renshaw		Buy	$12.00 -> $16.00	N/A
BHC Bausch Health Companies	2/16/2016	Initiated by	Rodman & Renshaw		Buy	$150.00	N/A
TMQ Trilogy Metals	2/11/2016	Reiterated by	Rodman & Renshaw		Buy	$1.40 -> $1.30	N/A
TMQ Trilogy Metals	2/10/2016	Target Lowered by	Rodman & Renshaw		Buy	$1.40 -> $1.30	N/A
SRAX SRAX	2/9/2016	Initiated by	Rodman & Renshaw		Buy	$1.50	N/A
BCRX BioCryst Pharmaceuticals	2/9/2016	Target Lowered by	Rodman & Renshaw		Buy	$24.00 -> $10.00	N/A
YTEN Yield10 Bioscience	2/9/2016	Initiated by	Rodman & Renshaw		Buy	$1,200.00	N/A
VNRX VolitionRx	2/1/2016	Initiated by	Rodman & Renshaw		Buy	$12.00	N/A
INO Inovio Pharmaceuticals	1/29/2016	Reiterated by	Rodman & Renshaw		Buy		N/A
IPWR Ideal Power	1/26/2016	Initiated by	Rodman & Renshaw		Buy	$12.00	N/A
AMSC American Superconductor	1/13/2016	Initiated by	Rodman & Renshaw		Buy	$10.00	N/A
NB NioCorp Developments	1/12/2016	Target Lowered by	Rodman & Renshaw		Buy	C$1.40 -> C$1.20	N/A
ORMP Oramed Pharmaceuticals	1/10/2016	Reiterated by	Rodman & Renshaw		Buy	$25.00	N/A
GGD GoGold Resources	12/21/2015	Target Raised by	Rodman & Renshaw			C$2.70 -> C$2.90	N/A
MVIS MicroVision	12/17/2015	Initiated by	Rodman & Renshaw		Buy	$3.50	N/A
CRMD CorMedix	12/16/2015	Initiated by	Rodman & Renshaw		Buy		N/A
VUZI Vuzix	12/10/2015	Initiated by	Rodman & Renshaw		Buy	$10.00	N/A
SRNE Sorrento Therapeutics	12/7/2015	Reiterated by	Rodman & Renshaw		Buy	$45.00	N/A
CRMD CorMedix	11/12/2015	Initiated by	Rodman & Renshaw		Buy	$32.50	N/A
AMRS Amyris	11/10/2015	Initiated by	Rodman & Renshaw		Buy	$60.00	N/A
BLDP Ballard Power Systems	10/5/2015	Reiterated by	Rodman & Renshaw		Buy		N/A
ORMP Oramed Pharmaceuticals	10/1/2015	Initiated by	Rodman & Renshaw		Buy	$24.00	N/A
EVOK Evoke Pharma	10/1/2015	Initiated by	Rodman & Renshaw		Buy	$324.00	N/A
CGRN Capstone Green Energy	9/22/2015	Initiated by	Rodman & Renshaw		Buy		N/A
BLDP Ballard Power Systems	8/20/2015	Initiated by	Rodman & Renshaw		Buy	$2.50	N/A
GEVO Gevo	8/19/2015	Initiated by	Rodman & Renshaw		Buy	$100.00	N/A
DGLY Digital Ally	7/30/2015	Reiterated by	Rodman & Renshaw		Buy	$24.00	N/A
AUMN Golden Minerals	7/18/2015	Target Lowered by	Rodman & Renshaw		Buy	$0.90 -> $0.50	N/A
BLDP Ballard Power Systems	7/14/2015	Initiated by	Rodman & Renshaw		Buy		N/A
DGLY Digital Ally	6/18/2015	Initiated by	Rodman & Renshaw		Buy	$24.00	N/A
CPRX Catalyst Pharmaceuticals	8/27/2012	Upgraded by	Rodman & Renshaw		Market Perform -> Outperform	$3.70	N/A
CYTK Cytokinetics	7/31/2012	Reiterated by	Rodman & Renshaw		Outperform	$2.00	N/A
ALNY Alnylam Pharmaceuticals	7/31/2012	Reiterated by	Rodman & Renshaw		Outperform	$22.00	N/A
BMY Bristol-Myers Squibb	7/27/2012	Target Raised by	Rodman & Renshaw		Outperform	$38.00 -> $39.50	N/A
AMGN Amgen	7/23/2012	Target Raised by	Rodman & Renshaw		Outperform	$73.00 -> $89.00	N/A
ALNY Alnylam Pharmaceuticals	7/16/2012	Reiterated by	Rodman & Renshaw		Outperform		N/A
ALGT Allegiant Travel	7/13/2012	Target Raised by	Rodman & Renshaw		Outperform	$72.00 -> $79.00	N/A
BMY Bristol-Myers Squibb	7/5/2012	Reiterated by	Rodman & Renshaw		Market Perform	$38.00	N/A

ASMB Assembly Biosciences	6/26/2012	Target Lowered by	Rodman & Renshaw			$11.00	N/A
RPMT Rego Payment Architectures	6/25/2012	Initiated by	Rodman & Renshaw		Outperform	$5.00	N/A
AMGN Amgen	6/21/2012	Target Raised by	Rodman & Renshaw		Outperform	$57.00 -> $73.00	N/A
MNOV MediciNova	6/19/2012	Reiterated by	Rodman & Renshaw		Outperform		N/A
DCO Ducommun	5/24/2012	Initiated by	Rodman & Renshaw		Market Perform		N/A
TTNP Titan Pharmaceuticals	5/14/2012	Initiated by	Rodman & Renshaw		Outperform		N/A
POWL Powell Industries	5/10/2012	Upgraded by	Rodman & Renshaw		Market Perform -> Outperform	$43.00	N/A
NPO EnPro Industries	5/4/2012	Target Raised by	Rodman & Renshaw		Outperform	$47.00 -> $50.00	N/A
RMTI Rockwell Medical	4/24/2012	Initiated by	Rodman & Renshaw		Outperform	$176.00	N/A
SYK Stryker	4/20/2012	Downgraded by	Rodman & Renshaw		Outperform -> Market Perform		N/A
PODD Insulet	4/18/2012	Upgraded by	Rodman & Renshaw		Market Perform -> Outperform		N/A
AEZS Aeterna Zentaris	4/3/2012	Downgraded by	Rodman & Renshaw		Market Perform		N/A
B Barnes Group	4/3/2012	Initiated by	Rodman & Renshaw		Outperform		N/A
TRS TriMas	3/15/2012	Initiated by	Rodman & Renshaw		Outperform	$32.00	N/A
OMER Omeros	3/13/2012	Target Raised by	Rodman & Renshaw		Outperform	$13.00 -> $16.00	N/A
AMGN Amgen	3/7/2012	Reiterated by	Rodman & Renshaw		Outperform	$57.00	N/A
VSTM Verastem	3/7/2012	Initiated by	Rodman & Renshaw		Buy -> Market Perform		N/A
ANIP ANI Pharmaceuticals	2/27/2012	Reiterated by	Rodman & Renshaw		Market Perform		N/A
MNTX Manitex International	2/23/2012	Target Raised by	Rodman & Renshaw			$10.00	N/A
MDGL Madrigal Pharmaceuticals	2/22/2012	Reiterated by	Rodman & Renshaw		Market Perform	$8.00	N/A
CTIC CTI BioPharma	2/21/2012	Initiated by	Rodman & Renshaw		Outperform		N/A
MGIC Magic Software Enterprises	2/15/2012	Target Raised by	Rodman & Renshaw		Outperform	$8.00 -> $10.00	N/A
ALNY Alnylam Pharmaceuticals	2/6/2012	Target Raised by	Rodman & Renshaw		Outperform	$19.00	N/A
DAL Delta Air Lines	2/6/2012	Reiterated by	Rodman & Renshaw		Outperform	$14.00	N/A
ALGT Allegiant Travel	2/2/2012	Target Raised by	Rodman & Renshaw			$62.00	N/A
POWL Powell Industries	1/26/2012	Initiated by	Rodman & Renshaw		Market Perform		N/A
SILC Silicom	1/24/2012	Target Raised by	Rodman & Renshaw		Outperform	$20.00 -> $25.00	N/A
BMY Bristol-Myers Squibb	1/23/2012	Reiterated by	Rodman & Renshaw		Outperform	$51.00	N/A
LUV Southwest Airlines	1/20/2012	Reiterated by	Rodman & Renshaw		Outperform	$12.00	N/A
AMGN Amgen	1/17/2012	Reiterated by	Rodman & Renshaw		Outperform	$57.00	N/A
INFI Infinity Pharmaceuticals	1/5/2012	Initiated by	Rodman & Renshaw		Market Perform		N/A
COOL Corner Growth Acquisition	1/5/2012	Initiated by	Rodman & Renshaw		Outperform	$7.00	N/A
MDGL Madrigal Pharmaceuticals	1/5/2012	Initiated by	Rodman & Renshaw		Outperform	$8.00	N/A
ALNY Alnylam Pharmaceuticals	1/4/2012	Reiterated by	Rodman & Renshaw		Outperform	$12.00	N/A
WWD Woodward	1/4/2012	Initiated by	Rodman & Renshaw		Outperform	$52.00	N/A
AMGN Amgen	12/23/2011	Reiterated by	Rodman & Renshaw		Outperform	$57.00	N/A
ABMD Abiomed	12/19/2011	Downgraded by	Rodman & Renshaw		Market Perform -> Underperform	$13.00	N/A
CGRN Capstone Green Energy	12/15/2011	Reiterated by	Rodman & Renshaw		Outperform	$2.50	N/A
ANIP ANI Pharmaceuticals	12/15/2011	Downgraded by	Rodman & Renshaw		Outperform -> Market Perform		N/A
INTC Intel	12/13/2011	Reiterated by	Rodman & Renshaw		Outperform	$27.00	N/A
BMY Bristol-Myers Squibb	12/13/2011	Target Lowered by	Rodman & Renshaw			$51.00	N/A
ALNY Alnylam Pharmaceuticals	12/12/2011	Reiterated by	Rodman & Renshaw		Outperform	$12.00	N/A
BMY Bristol-Myers Squibb	12/12/2011	Reiterated by	Rodman & Renshaw		Outperform	$52.50	N/A
SPPI Spectrum Pharmaceuticals	12/9/2011	Reiterated by	Rodman & Renshaw		Outperform		N/A
OMER Omeros	12/5/2011	Upgraded by	Rodman & Renshaw		Market Perform -> Outperform	$13.00	N/A
ROG Rogers	12/2/2011	Initiated by	Rodman & Renshaw		Outperform	$55.00	N/A
ALNY Alnylam Pharmaceuticals	12/1/2011	Reiterated by	Rodman & Renshaw		Outperform		N/A
AMGN Amgen	12/1/2011	Initiated by	Rodman & Renshaw		Outperform	$62.00	N/A
CRIS Curis	11/30/2011	Reiterated by	Rodman & Renshaw		Outperform	$30.00	N/A
EW Edwards Lifesciences	11/29/2011	Reiterated by	Rodman & Renshaw		Market Perform		N/A
AAPL Apple	11/29/2011	Reiterated by	Rodman & Renshaw		Outperform	$16.07	N/A
CGRN Capstone Green Energy	11/22/2011	Reiterated by	Rodman & Renshaw		Outperform		N/A
SPPI Spectrum Pharmaceuticals	11/21/2011	Reiterated by	Rodman & Renshaw		Outperform	$12.00	N/A
LUV Southwest Airlines	11/21/2011	Reiterated by	Rodman & Renshaw		Outperform	$12.00	N/A
DELL Dell Technologies	11/15/2011	Reiterated by	Rodman & Renshaw		Outperform	$18.00	N/A
MNTX Manitex International	11/15/2011	Initiated by	Rodman & Renshaw		Outperform	$6.50	N/A
ALIM Alimera Sciences	11/14/2011	Downgraded by	Rodman & Renshaw		Outperform -> Market Perform		N/A
AEZS Aeterna Zentaris	11/14/2011	Reiterated by	Rodman & Renshaw		Outperform	$75.00	N/A
EW Edwards Lifesciences	11/11/2011	Reiterated by	Rodman & Renshaw		Market Perform		N/A
ADNT Adient	11/11/2011	Initiated by	Rodman & Renshaw		Market Perform		N/A

MarketBeat Community Rating for Rodman & Renshaw

Community Ranking:		2.8 out of 5 ( 2.8 of 5 stars)
Outperform Votes:		17,923 (Vote Outperform)
Underperform Votes:		14,326 (Vote Underperform)
Total Votes:		32,249

MarketBeat's community ratings are surveys of what our community members think about Rodman & Renshaw and other research firms. Vote "Outperform" if you believe Rodman & Renshaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Rodman & Renshaw's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rodman & Renshaw Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Rodman & Renshaw

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info